These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24039692)

  • 1. Cdk5 inhibitory peptide (CIP) inhibits Cdk5/p25 activity induced by high glucose in pancreatic beta cells and recovers insulin secretion from p25 damage.
    Zheng YL; Li C; Hu YF; Cao L; Wang H; Li B; Lu XH; Bao L; Luo HY; Shukla V; Amin ND; Pant HC
    PLoS One; 2013; 8(9):e63332. PubMed ID: 24039692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of p35 in Min6 pancreatic beta cells induces a stressed neuron-like apoptosis.
    Zheng YL; Hu YF; Zhang A; Wang W; Li B; Amin N; Grant P; Pant HC
    J Neurol Sci; 2010 Dec; 299(1-2):101-7. PubMed ID: 20926102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 24-residue peptide (p5), derived from p35, the Cdk5 neuronal activator, specifically inhibits Cdk5-p25 hyperactivity and tau hyperphosphorylation.
    Zheng YL; Amin ND; Hu YF; Rudrabhatla P; Shukla V; Kanungo J; Kesavapany S; Grant P; Albers W; Pant HC
    J Biol Chem; 2010 Oct; 285(44):34202-12. PubMed ID: 20720012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cdk5-dependent regulation of glucose-stimulated insulin secretion.
    Wei FY; Nagashima K; Ohshima T; Saheki Y; Lu YF; Matsushita M; Yamada Y; Mikoshiba K; Seino Y; Matsui H; Tomizawa K
    Nat Med; 2005 Oct; 11(10):1104-8. PubMed ID: 16155576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AAV9-Mediated Cdk5 Inhibitory Peptide Reduces Hyperphosphorylated Tau and Inflammation and Ameliorates Behavioral Changes Caused by Overexpression of p25 in the Brain.
    Xu M; Huang Y; Song P; Huang Y; Huang W; Zhang HT; Hu Y
    J Alzheimers Dis; 2019; 70(2):573-585. PubMed ID: 31256130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TFP5, a Peptide Derived from Cdk5 Activator p35, Protects Pancreatic β Cells from Glucose Toxicity.
    Liu SY; Cao SL; Luo HY; Bao L; E J; Li B; Lan XM; Zhang GQ; Bao X; Zheng YL
    Bull Exp Biol Med; 2023 Nov; 176(1):19-25. PubMed ID: 38087140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptides derived from Cdk5 activator p35, specifically inhibit deregulated activity of Cdk5.
    Kesavapany S; Zheng YL; Amin N; Pant HC
    Biotechnol J; 2007 Aug; 2(8):978-87. PubMed ID: 17526058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A peptide derived from cyclin-dependent kinase activator (p35) specifically inhibits Cdk5 activity and phosphorylation of tau protein in transfected cells.
    Zheng YL; Li BS; Amin ND; Albers W; Pant HC
    Eur J Biochem; 2002 Sep; 269(18):4427-34. PubMed ID: 12230554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myricetin Protects Against High Glucose-Induced β-Cell Apoptosis by Attenuating Endoplasmic Reticulum Stress via Inactivation of Cyclin-Dependent Kinase 5.
    Karunakaran U; Elumalai S; Moon JS; Jeon JH; Kim ND; Park KG; Won KC; Leem J; Lee IK
    Diabetes Metab J; 2019 Apr; 43(2):192-205. PubMed ID: 30688049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific inhibition of p25/Cdk5 activity by the Cdk5 inhibitory peptide reduces neurodegeneration in vivo.
    Sundaram JR; Poore CP; Sulaimee NH; Pareek T; Asad AB; Rajkumar R; Cheong WF; Wenk MR; Dawe GS; Chuang KH; Pant HC; Kesavapany S
    J Neurosci; 2013 Jan; 33(1):334-43. PubMed ID: 23283346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TFP5, a peptide derived from p35, a Cdk5 neuronal activator, rescues cortical neurons from glucose toxicity.
    Binukumar BK; Zheng YL; Shukla V; Amin ND; Grant P; Pant HC
    J Alzheimers Dis; 2014; 39(4):899-909. PubMed ID: 24326517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myricetin prevents thapsigargin-induced CDK5-P66Shc signalosome mediated pancreatic β-cell dysfunction.
    Karunakaran U; Lee JE; Elumalai S; Moon JS; Won KC
    Free Radic Biol Med; 2019 Sep; 141():59-66. PubMed ID: 31163256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Cdk5 inhibitor enhances the induction of insulin secretion by exendin-4 both in vitro and in vivo.
    Kitani K; Oguma S; Nishiki T; Ohmori I; Galons H; Matsui H; Meijer L; Tomizawa K
    J Physiol Sci; 2007 Aug; 57(4):235-9. PubMed ID: 17854513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin-dependent kinase 5 promotes pancreatic β-cell survival via Fak-Akt signaling pathways.
    Daval M; Gurlo T; Costes S; Huang CJ; Butler PC
    Diabetes; 2011 Apr; 60(4):1186-97. PubMed ID: 21378178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cyclin-dependent kinase 5 activity protects pancreatic beta cells from glucotoxicity.
    Ubeda M; Rukstalis JM; Habener JF
    J Biol Chem; 2006 Sep; 281(39):28858-64. PubMed ID: 16887799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cdk5 Inhibitory Peptide Prevents Loss of Neurons and Alleviates Behavioral Changes in p25 Transgenic Mice.
    Huang Y; Huang W; Huang Y; Song P; Zhang M; Zhang HT; Pan S; Hu Y
    J Alzheimers Dis; 2020; 74(4):1231-1242. PubMed ID: 32144987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Cdk5-derived peptide inhibits Cdk5/p25 activity and improves neurodegenerative phenotypes.
    Pao PC; Seo J; Lee A; Kritskiy O; Patnaik D; Penney J; Raju RM; Geigenmuller U; Silva MC; Lucente DE; Gusella JF; Dickerson BC; Loon A; Yu MX; Bula M; Yu M; Haggarty SJ; Tsai LH
    Proc Natl Acad Sci U S A; 2023 Apr; 120(16):e2217864120. PubMed ID: 37043533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cdk5 phosphorylates PLD2 to mediate EGF-dependent insulin secretion.
    Lee HY; Jung H; Jang IH; Suh PG; Ryu SH
    Cell Signal; 2008 Oct; 20(10):1787-94. PubMed ID: 18625302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p10, the N-terminal domain of p35, protects against CDK5/p25-induced neurotoxicity.
    Zhang L; Liu W; Szumlinski KK; Lew J
    Proc Natl Acad Sci U S A; 2012 Dec; 109(49):20041-6. PubMed ID: 23151508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons.
    Zheng YL; Kesavapany S; Gravell M; Hamilton RS; Schubert M; Amin N; Albers W; Grant P; Pant HC
    EMBO J; 2005 Jan; 24(1):209-20. PubMed ID: 15592431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.